Company: MYSZ
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024073
Chunk: 9

Company: My Size, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 9
---
 was incorporated and commenced operations in September 1999, as Topspin Medical Inc. (“Topspin”), a private
    company registered in the State of Delaware. In December 2013, the Company changed its name to Knowledgetree Ventures Inc. Subsequently,
    in February 2014, the Company changed its name to My Size, Inc. Topspin was engaged, through its Israeli subsidiary, in research
    and development in the field of cardiology and urology.
     
    On
    July 25, 2016, the Company’s common stock began publicly trading on the Nasdaq Capital Market under the symbol “MYSZ”.
     
    From
    September 1, 2005 to March 27, 2024, the Company’s common stock was traded on the Tel Aviv Stock Exchange.
     
    On
    May 9, 2025, a newly-formed, wholly-owned subsidiary of the Company, New Percentil, S.L., a limited liability company incorporated
    under the laws of Spain (“New Percentil”), entered into a production unit transfer agreement with Casi Nuevo Kids, S.L.,
    a limited liability company incorporated under the laws of Spain (“Casi Nuevo”), pursuant to which New Percentil acquired
    (the “Acquisition”) a production unit of Casi Nuevo with a trade name of Percentil that was judicially awarded to the
    Company in April 2025 within the framework of insolvency proceedings of Casi Nuevo filed with Commercial Court No. 13 of Madrid (Spain).
    The Acquisition was completed on May 9, 2025.
     
    The Company paid a total transaction value of €610 (approximately
$679), consisting of a €40 (approximately $45) cash payment and the assumption of certain customer and labor liabilities and debt
and social security payments in the aggregate amount of approximately €570 (approximately $634). The Acquisition was financed through
existing cash reserves and does not involve the issuance of additional shares or debt.

    7

MY
SIZE, INC. AND ITS SUBSIDIARIES

Notes
to Condensed Consolidated Interim Financial Statements (Unaudited)

U.S.
dollars in thousands (except share data and per share data)

    b.
    Since
                                            inception, the Company has incurred significant losses and negative cash flows from operations
                                            and has an accumulated deficit of $65,386.
                                                          
                                                         The Company has financed its operations mainly